Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic

Chronic liver disease (CLD) and cirrhosis accounts for approximately 2 million deaths annually worldwide. CLD and cirrhosis-related mortality has increased steadily in the United States.(1,2) With the global pandemic of coronavirus disease 2019 (COVID-19), patients with CLD and cirrhosis represent a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Donghee, Bonham, Clark Andrew, Konyn, Peter, Cholankeril, George, Ahmed, Aijaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271030/
https://www.ncbi.nlm.nih.gov/pubmed/34256143
http://dx.doi.org/10.1016/j.cgh.2021.07.009
_version_ 1783720921833406464
author Kim, Donghee
Bonham, Clark Andrew
Konyn, Peter
Cholankeril, George
Ahmed, Aijaz
author_facet Kim, Donghee
Bonham, Clark Andrew
Konyn, Peter
Cholankeril, George
Ahmed, Aijaz
author_sort Kim, Donghee
collection PubMed
description Chronic liver disease (CLD) and cirrhosis accounts for approximately 2 million deaths annually worldwide. CLD and cirrhosis-related mortality has increased steadily in the United States.(1,2) With the global pandemic of coronavirus disease 2019 (COVID-19), patients with CLD and cirrhosis represent a vulnerable population at higher risk for complications and mortality.(3,4) Although high mortality from COVID-19 among patients with CLD and cirrhosis have been reported,(5) national trends in mortality related to CLD and cirrhosis before and during the COVID-19 pandemic have not been assessed. This study estimated the temporal quarterly trends in CLD and cirrhosis-related mortality in the United States from 2017 Q1 to 2020 Q3 using provisional data releases from the National Vital Statistics System.(6,7)
format Online
Article
Text
id pubmed-8271030
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher by the AGA Institute
record_format MEDLINE/PubMed
spelling pubmed-82710302021-07-20 Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic Kim, Donghee Bonham, Clark Andrew Konyn, Peter Cholankeril, George Ahmed, Aijaz Clin Gastroenterol Hepatol Original Article Chronic liver disease (CLD) and cirrhosis accounts for approximately 2 million deaths annually worldwide. CLD and cirrhosis-related mortality has increased steadily in the United States.(1,2) With the global pandemic of coronavirus disease 2019 (COVID-19), patients with CLD and cirrhosis represent a vulnerable population at higher risk for complications and mortality.(3,4) Although high mortality from COVID-19 among patients with CLD and cirrhosis have been reported,(5) national trends in mortality related to CLD and cirrhosis before and during the COVID-19 pandemic have not been assessed. This study estimated the temporal quarterly trends in CLD and cirrhosis-related mortality in the United States from 2017 Q1 to 2020 Q3 using provisional data releases from the National Vital Statistics System.(6,7) by the AGA Institute 2021-12 2021-07-10 /pmc/articles/PMC8271030/ /pubmed/34256143 http://dx.doi.org/10.1016/j.cgh.2021.07.009 Text en © 2021 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Kim, Donghee
Bonham, Clark Andrew
Konyn, Peter
Cholankeril, George
Ahmed, Aijaz
Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic
title Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic
title_full Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic
title_fullStr Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic
title_full_unstemmed Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic
title_short Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic
title_sort mortality trends in chronic liver disease and cirrhosis in the united states, before and during covid-19 pandemic
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271030/
https://www.ncbi.nlm.nih.gov/pubmed/34256143
http://dx.doi.org/10.1016/j.cgh.2021.07.009
work_keys_str_mv AT kimdonghee mortalitytrendsinchronicliverdiseaseandcirrhosisintheunitedstatesbeforeandduringcovid19pandemic
AT bonhamclarkandrew mortalitytrendsinchronicliverdiseaseandcirrhosisintheunitedstatesbeforeandduringcovid19pandemic
AT konynpeter mortalitytrendsinchronicliverdiseaseandcirrhosisintheunitedstatesbeforeandduringcovid19pandemic
AT cholankerilgeorge mortalitytrendsinchronicliverdiseaseandcirrhosisintheunitedstatesbeforeandduringcovid19pandemic
AT ahmedaijaz mortalitytrendsinchronicliverdiseaseandcirrhosisintheunitedstatesbeforeandduringcovid19pandemic

Ejemplares similares